)
Coloplast (COLO) investor relations material
Coloplast Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Financial performance and guidance
Q1 2025/26 organic revenue grew 6%, with reported growth flat due to currency and divestment impacts; EBIT before special items decreased 3% to DKK 1,850 million, with a margin of 26%.
Free cash flow was DKK 1,821 million, with a FCF-to-sales ratio of 26%, supported by lower net financial items.
FY 2025/26 guidance remains at around 7% organic growth and 7% EBIT growth in constant currencies, with ROIC expected to improve by 1 percentage point.
Reported growth in DKK is expected at 4%, with a 3%-point negative impact from currencies and a small negative impact from the skin care divestment.
Tax rate is expected to remain around 22% during the strategic period, benefiting from recent IP transfers.
Business segment performance
Ostomy Care grew 4% organically, impacted by negative growth in China and a high baseline in the US; growth expected to pick up later in the year.
Continence Care delivered 7% organic growth, led by the Luja™ catheter platform for both male and female users.
Voice & Respiratory Care grew 8%, driven by Laryngectomy and broad-based geographic growth.
Wound & Tissue Repair grew 5%, with Kerecis delivering 10% organic growth but facing sales disruption from Medicare reimbursement changes.
Interventional Urology grew 8%, led by strong US Men's Health performance and recovery in Kidney & Bladder Health.
Strategic priorities and Impact4
Impact4 strategy focuses on four pillars: innovative customer offerings, efficiency gains, technology adoption, and cultivating a winning, sustainable company.
Ambition for 7-8% organic revenue growth (5-year CAGR) and ROIC above 20% by FY 2029/30.
Dynamic resource allocation is fueling high-potential areas such as US Chronic Care, Kerecis, and Intibia commercialization.
All business segments are expected to contribute to growth, with Chronic Care as the largest driver.
Next Coloplast earnings date
Next Coloplast earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)